New publication by our #TBunit. A meta-analysis of 30 studies across 21 countries (2011-2024) found 18% of rifampicin-resistant TB patients diagnosed via Xpert never start treatment. Congratulation to Christelle Jouego for leading this study! @itmantwerp.bsky.social https://gh.bmj.com/content/10/1/e015977